In the current study, we focused on Merlin, another upstream regulator of Hippo signaling (17–20) and a classic tumor suppressor whose mutations underlie the human disease Neurofibromatosis Type II (NF2) (21). Here, NF2 is linked to NF2-related schwannomatosis.